Jack A. DeHovitz, MD, MPH

Recent Publications

Hogben M, Wilson T, Feldman J, Landesman S, DeHovitz JA. The influence of women’s HIV-related knowledge and exposure fears on behavior change and incident STDs. Women and Health 2000;30:25-37.

Wilson TE, Uuskula A, Feldman J, Holman S, DeHovitz JA. A case-control study of beliefs and behaviors associated with STD occurrence in Estonia. J Sex Trans Dis 2001;28:624-629.

Greenblatt RM, Jacobson LP, Levine AM, Melnick S, Anastos K, Cohen M, DeHovitz JA, Young M, Buns D, Miotti P, Koelle D. Human herpesvirus 8 (HHV-8) infection and Kaposi’s sarcoma among HIV-infected and uninfected women. J Infect Dis 2001; 183:1130-1134.

Hobgen M, Gange SJ, Watts DH, Robison E, Young M, Richardson J, Cohen M, DeHovitz J. The effect of sexual and physical violence on risky sexual behavior and STDs among a cohort of HIV seropositive women. AIDS and Behavior 2001; 5(4):353-361.

Kissin DM, Holman S, Minkoff HL, DeMeo L, McCormack WM, DeHovitz J. Epidemiology and natural history of ligase chain reaction detected chlamydial and gonococcal infections. Sexually Transmitted Infections 2002;78:208-209.

Uuskula A, Kalikova A, Zilmer K, Tammai L, DeHovitz J. The role of injection drug use in the emergence of HIV in Estonia. Int J Infect Dis 2002;6(1):23-27.

Gyarmathy VA, McNutt LA, Molnar A, Morse DL, DeHovitz J, Ujhelyi E, Szamado S. Evaluation of a comprehensive AIDS education curriculum in Hungary—the role of good educators. J Adolesc.2002 Oct:25(5):495-508.

Feldman JG, Goldwasser P, Holman S, DeHovitz J, Minkoff H. C-Reactive Protein Is an Independent predictor of mortality in women with HIV-1 infection. JAIDS 2003;32(2):210-4.

Maurer T, Rodrigues LKE, Ameli N, Phanuphak N, Gange SJ, DeHovitz J, et al. The effect of highly active antiretro-viral therapy on dermatologic disease in a longitudinal study of HIV-1 infected women. CID 2004; 38(4):579-84.

Uuskula A, Heimer R, DeHovitz J, Fischer K, McNutt LA. Surveillance of HIV, Hepatitis B Virus, and Hepatitis C Virus in an Estonian Injection Drug-Using Population: Sensitivity and Specificity of Testing Syringes for Public Health Surveillance. J Infect Dis. 2006;193: 455-7.

Sackoff JE, Pfeiffer MR, Driver CR, Streett LS, Munsiff SS, DeHovitz JA. Tuberculosis prevention for non-US born pregnant women. AM J Obstet Gynecol. 2006 Feb:194(2):451-6.

Vaamond CM, Hoover DR, Anastos K, Tan T, Shi Q, Gao W, Kovacs A, Cohen M, DeHovitz J, Glesby MJ. Factors associated with poor immunologic response to virologic suppression by highly active antiretroviral therapy in HIV-infected women. AIDS Res Hum Retroviruses. 2006; Mar: 22(3):222-31.

DeHovitz JA, Feldman JG, Holman S, Minkoff H. High Sensitivity C-Reactive Protein and Response to Highly Active Antiretroviral Therapy in Women With HIV-1 Infection. JAIDS. 2006 July;42(3):383-4.

Uuskula, A, McNutt LA, DeHovitz JA, Fischer, K, Heimer, R. High prevalence of blood-borne virus infections and high-risk behaviour among injecting drug users in Tallinn, Estonia. Int J STD & AIDS. 2007; Jan:18 41-46.

Ghazaryan, LR, Muse, AG, Sarkisian TF, Morse, DL, DeHovitz JA. A survey to estimate the prevalence of genital Chlamydia trachomatis among women in Armenia. JIDC 2007; 1(2): 214-216.

Uusküla A, Kals M, Rajaleid K, Abel K, Talu A, Rüütel K, Platt L, Rhodes T, DeHovitz J, Des Jarlais D. High-prevalence and high-estimated incidence of HIV infection among new injecting drug users in Estonia: need for large scale prevention programs. J Public Health (Oxf). In Press.